Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Postmarket Surveillance Reform Board Gets Injection Of Device Industry Experience

This article was originally published in The Gray Sheet

Executive Summary

The appointments of three device industry veterans to the Brookings-administered, and partially FDA-funded, Planning Board is intended to expand the range of input in the next phase of development of a new National Medical Device Surveillance System.

Advertisement

Related Content

Negotiating Prices For Real-World Data Can Lower FDA Submission Costs, Shuren Says
Device Surveillance Reform Board Looks To Add Small-Firm Experience
Task Force Advocates Making Registries Better Than Sum Of Their Parts
Planning Board Proposes Postmarket Device Surveillance Timeline
Foundry Founders Take Stock

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

MT034468

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel